SCHEMBL18599321

SCHEMBL18599321

CCc1cccc(-c2cn(-c3ccnc4[nH]ccc34)nc2C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.43
NUDT1 P36639 3/20 0.42
PRKCI P41743 4/20 0.41
BRAF P15056 5/20 0.39
IKBKB O14920 2/20 0.39
CHUK O15111 2/20 0.39
AURKB Q96GD4 2/20 0.39
DAPK3 O43293 1/20 0.39
JAK2 O60674 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
PAK4 O96013 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
IGF1R P08069 1/20 0.39
FGFR1 P11362 1/20 0.39
PRKACA P17612 1/20 0.39
FLT1 P17948 1/20 0.39
LTK P29376 1/20 0.39
GRK5 P34947 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100558 0.91 CDK8 (0.42) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL29541690 0.91 CDK8 (0.42) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL29540479 0.85 MAP4K4 (0.46) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL98811 0.85 MAP4K4 (0.46) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL29540441 0.84 AURKB (0.56) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL98273 0.84 AURKB (0.56) LRRK2NUDT1PRKCIBRAFIKBKB
SCHEMBL99271 0.82 BRD4 (0.46) LRRK2NUDT1PRKCIIKBKBCHUK
SCHEMBL29540881 0.82 BRD4 (0.46) LRRK2NUDT1PRKCIIKBKBCHUK
SCHEMBL16692485 0.80 PRKCI (0.48) LRRK2NUDT1PRKCIIKBKBCHUK
SCHEMBL14494697 0.79 NUDT1 (0.64) LRRK2NUDT1PRKCIIKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348023-B9 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE HOLDINGS CORP (US) 2017-03-08 EP disclosed